PHARMABCINE INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PHARMABCINE INC..The latest application filed is for "anti-tie2 antibody and use thereof".

Company Profile

6.18.16

PHARMABCINE INC. - Daejeon N/A KR
PHARMABCINE INC. - Daejeon-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-PD-L1 antibody and use thereof Grant 11,407,834 - Ahn , et al. August 9, 2	2022-08-09
Anti-VISTA antibody and use thereof Grant 11,407,833 - Lee , et al. August 9, 2	2022-08-09
Anti-tie2 Antibody And Use Thereof App 20220213201 - LEE; Eun-Ah ; et al.	2022-07-07
Anti-ang2 Antibody And Use Thereof App 20220204603 - NAM; Ju Ryoung ; et al.	2022-06-30
Anti-pd-l1 Antibody And Use Thereof App 20210054078 - Ahn; Sungho ; et al.	2021-02-25
Anti-vegfr-2 Antibody App 20210009695 - LEE; Weon-Sup ; et al.	2021-01-14
Anti-vista Antibody And Use Thereof App 20200407449 - Lee; Youngae ; et al.	2020-12-31
EGFRvIII antibody and composition comprising same Grant 10,597,457 - Yoon , et al.	2020-03-24
Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same Grant 10,155,817 - Kim , et al. Dec	2018-12-18
Dual targeting antibody of novel form, and use thereof Grant 10,125,194 - Yoo , et al. November 13, 2	2018-11-13
Human antibody specific to c-Met and preparation method thereof Grant 10,106,622 - Yoo , et al. October 23, 2	2018-10-23
Dual-target Antibody Targeting Vegfr-2 And Dll4, And Pharmaceutical Composition Including Same App 20180208660 - Kim; Joong Kyu ; et al.	2018-07-26
Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same Grant 9,963,512 - Kim , et al. May 8, 2	2018-05-08
Novel Egfrviii Antibody And Composition Comprising Same App 20170327585 - Yoon; Jae Bong ; et al.	2017-11-16
Human Antibody Specific To C-met And Preparation Method Thereof App 20170233492 - Yoo; Jinsang ; et al.	2017-08-17
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof Grant 9,249,219 - Yoo , et al. February 2, 2	2016-02-02
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof Grant 9,249,220 - Yoo , et al. February 2, 2	2016-02-02
Dual-target Antibody Targeting Vegfr-2 And Dll4, And Pharmaceutical Composition Including Same App 20150315277 - Kim; Joong Kyu ; et al.	2015-11-05
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof Grant 9,150,650 - Yoo , et al. October 6, 2	2015-10-06
Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof App 20140288274 - Yoo; Jin-San ; et al.	2014-09-25
Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof App 20140275488 - YOO; Jin-San ; et al.	2014-09-18
Dual Targeting Antibody Of Novel Form, And Use Thereof App 20120065380 - Yoo; Jin San ; et al.	2012-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.